Although generalized convulsive status epilepticus (GCSE) is a life-threatening emergency,
evidence-based data to guide initial drug treatment choices are lacking in the Chinese
population. The investigators conduct this prospective randomized controlled trial to
evaluate the relative efficacy and safety of intravenous (IV) phenobarbital (PB) and
valproate (VPA) in patients with GCSE.